124 related articles for article (PubMed ID: 16855155)
1. Revisiting the toxicity of low-dose glucocorticoids: risks and fears.
Da Silva JA; Jacobs JW; Bijlsma JW
Ann N Y Acad Sci; 2006 Jun; 1069():275-88. PubMed ID: 16855155
[TBL] [Abstract][Full Text] [Related]
2. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy.
Bijlsma JW; van der Goes MC; Hoes JN; Jacobs JW; Buttgereit F; Kirwan J
Ann N Y Acad Sci; 2010 Apr; 1193():123-6. PubMed ID: 20398017
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of glucocorticoids in rheumatoid arthritis.
Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
[TBL] [Abstract][Full Text] [Related]
6. Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years.
Santiago T; da Silva JA
Ann N Y Acad Sci; 2014 May; 1318():41-9. PubMed ID: 24814757
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term safety of glucocorticoids in rheumatoid arthritis.
Saag KG
Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():21-5. PubMed ID: 23259654
[TBL] [Abstract][Full Text] [Related]
8. Safety of glucocorticoids in rheumatoid arthritis: evidence from recent clinical trials.
Santiago T; da Silva JA
Neuroimmunomodulation; 2015; 22(1-2):57-65. PubMed ID: 25228045
[TBL] [Abstract][Full Text] [Related]
9. [Glucocorticoids in pediatrics].
Radmanović SZ
Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():58-62. PubMed ID: 18193804
[TBL] [Abstract][Full Text] [Related]
10. Developments in glucocorticoid therapy.
Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids in early rheumatoid arthritis.
Davey M; Buchbinder R
Aust Fam Physician; 2008; 37(1-2):31-2. PubMed ID: 18239749
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
Boers M
Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):21-9. PubMed ID: 15123035
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid safety for treating rheumatoid arthritis.
Rasch LA; Bultink IE; van Tuyl LH; Lems WF
Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
[TBL] [Abstract][Full Text] [Related]
15. Studying the benefit/risk ratio of glucocorticoids in rheumatoid arthritis.
Boers M
J Rheumatol; 2007 Apr; 34(4):661-3. PubMed ID: 17407225
[No Abstract] [Full Text] [Related]
16. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
Di Munno O; Delle Sedie A
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
[TBL] [Abstract][Full Text] [Related]
17. Dose-related patterns of glucocorticoid-induced side effects.
Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
Ann Rheum Dis; 2009 Jul; 68(7):1119-24. PubMed ID: 18684744
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
Kirwan J; Power L
Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
[TBL] [Abstract][Full Text] [Related]
19. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis.
Hoes JN; Jacobs JW; Verstappen SM; Bijlsma JW; Van der Heijden GJ
Ann Rheum Dis; 2009 Dec; 68(12):1833-8. PubMed ID: 19066177
[TBL] [Abstract][Full Text] [Related]
20. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
